
Lynne Ann Gurley
Supervisory Patent Examiner (ID: 17161, Phone: (571)272-1670 , Office: P/2811 )
| Most Active Art Unit | 2812 |
| Art Unit(s) | 2814, 1104, 2811, 1763, 2899, 2812 |
| Total Applications | 979 |
| Issued Applications | 787 |
| Pending Applications | 38 |
| Abandoned Applications | 157 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 20293960
[patent_doc_number] => 20250319203
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-10-16
[patent_title] => COMPLEX AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 19/245463
[patent_app_country] => US
[patent_app_date] => 2025-06-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11347
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19245463
[rel_patent_id] =>[rel_patent_doc_number] =>) 19/245463 | COMPLEX AND USE THEREOF | Jun 22, 2025 | Pending |
Array
(
[id] => 19034430
[patent_doc_number] => 20240084245
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-03-14
[patent_title] => MODIFIED CYANOBACTERIUM, MODIFIED CYANOBACTERIUM PRODUCTION METHOD, AND PROTEIN PRODUCTION METHOD
[patent_app_type] => utility
[patent_app_number] => 18/456037
[patent_app_country] => US
[patent_app_date] => 2023-08-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16930
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18456037
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/456037 | MODIFIED CYANOBACTERIUM, MODIFIED CYANOBACTERIUM PRODUCTION METHOD, AND PROTEIN PRODUCTION METHOD | Aug 24, 2023 | Pending |
Array
(
[id] => 18707580
[patent_doc_number] => 20230330157
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-19
[patent_title] => MODULATION OF MICROBIOTA FUNCTION BY GENE THERAPY OF THE MICROBIOME TO PREVENT, TREAT OR CURE MICROBIOME-ASSOCIATED DISEASES OR DISORDERS
[patent_app_type] => utility
[patent_app_number] => 18/319158
[patent_app_country] => US
[patent_app_date] => 2023-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 47821
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18319158
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/319158 | MODULATION OF MICROBIOTA FUNCTION BY GENE THERAPY OF THE MICROBIOME TO PREVENT, TREAT OR CURE MICROBIOME-ASSOCIATED DISEASES OR DISORDERS | May 16, 2023 | Pending |
Array
(
[id] => 18649842
[patent_doc_number] => 20230295667
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-21
[patent_title] => USE OF ANTI-CRISPR AGENTS TO CONTROL EDITING IN HUMAN EMBRYOS
[patent_app_type] => utility
[patent_app_number] => 18/121759
[patent_app_country] => US
[patent_app_date] => 2023-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17497
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18121759
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/121759 | USE OF ANTI-CRISPR AGENTS TO CONTROL EDITING IN HUMAN EMBRYOS | Mar 14, 2023 | Pending |
Array
(
[id] => 18986456
[patent_doc_number] => 20240058425
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-22
[patent_title] => SYSTEMS AND METHODS FOR GENOME-WIDE ANNOTATION OF GENE REGULATORY ELEMENTS LINKED TO CELL FITNESS
[patent_app_type] => utility
[patent_app_number] => 18/180718
[patent_app_country] => US
[patent_app_date] => 2023-03-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 43861
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18180718
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/180718 | SYSTEMS AND METHODS FOR GENOME-WIDE ANNOTATION OF GENE REGULATORY ELEMENTS LINKED TO CELL FITNESS | Mar 7, 2023 | Pending |
Array
(
[id] => 18597580
[patent_doc_number] => 20230272376
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-31
[patent_title] => METHODS AND COMPOSITIONS FOR THE ADAR-MEDIATED EDITING OF METHYL-CPG BINDING PROTEIN 2 (MECP2)
[patent_app_type] => utility
[patent_app_number] => 17/985970
[patent_app_country] => US
[patent_app_date] => 2022-11-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 51467
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17985970
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/985970 | METHODS AND COMPOSITIONS FOR THE ADAR-MEDIATED EDITING OF METHYL-CPG BINDING PROTEIN 2 (MECP2) | Nov 13, 2022 | Pending |
Array
(
[id] => 18347361
[patent_doc_number] => 20230135471
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-04
[patent_title] => UBIQUITIN VARIANTS WITH IMPROVED AFFINITY FOR 53BP1
[patent_app_type] => utility
[patent_app_number] => 17/952252
[patent_app_country] => US
[patent_app_date] => 2022-09-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 36041
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -34
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17952252
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/952252 | UBIQUITIN VARIANTS WITH IMPROVED AFFINITY FOR 53BP1 | Sep 23, 2022 | Pending |
Array
(
[id] => 18567407
[patent_doc_number] => 20230257739
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-17
[patent_title] => EFFECTOR PROTEINS AND METHODS OF USE
[patent_app_type] => utility
[patent_app_number] => 17/935042
[patent_app_country] => US
[patent_app_date] => 2022-09-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 97284
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17935042
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/935042 | EFFECTOR PROTEINS AND METHODS OF USE | Sep 22, 2022 | Pending |
Array
(
[id] => 18360039
[patent_doc_number] => 20230141630
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-11
[patent_title] => Rolling Circle Reverse Transcription of Circular RNA
[patent_app_type] => utility
[patent_app_number] => 17/820372
[patent_app_country] => US
[patent_app_date] => 2022-08-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16869
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17820372
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/820372 | Rolling Circle Reverse Transcription of Circular RNA | Aug 16, 2022 | Pending |
Array
(
[id] => 18336052
[patent_doc_number] => 20230128001
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-27
[patent_title] => HIV ANTIGENS AND MHC COMPLEXES
[patent_app_type] => utility
[patent_app_number] => 17/817312
[patent_app_country] => US
[patent_app_date] => 2022-08-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 78487
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17817312
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/817312 | HIV ANTIGENS AND MHC COMPLEXES | Aug 2, 2022 | Pending |
Array
(
[id] => 18211791
[patent_doc_number] => 20230058054
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-23
[patent_title] => CRISPR/CAS SYSTEM AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/851030
[patent_app_country] => US
[patent_app_date] => 2022-06-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28832
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -62
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17851030
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/851030 | CRISPR/CAS SYSTEM AND USES THEREOF | Jun 27, 2022 | Abandoned |
Array
(
[id] => 18093485
[patent_doc_number] => 20220411826
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-29
[patent_title] => CO-OPTING REGULATORY BYPASS REPAIR OF GENETIC DISEASES
[patent_app_type] => utility
[patent_app_number] => 17/845447
[patent_app_country] => US
[patent_app_date] => 2022-06-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30913
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17845447
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/845447 | CO-OPTING REGULATORY BYPASS REPAIR OF GENETIC DISEASES | Jun 20, 2022 | Pending |
Array
(
[id] => 18895568
[patent_doc_number] => 20240011053
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-01-11
[patent_title] => Method of early diagnosis and composition of gRNA for treating mental health diseases using genome editing and cell and gene therapy
[patent_app_type] => utility
[patent_app_number] => 17/832572
[patent_app_country] => US
[patent_app_date] => 2022-06-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5613
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -81
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17832572
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/832572 | Method of early diagnosis and composition of gRNA for treating mental health diseases using genome editing and cell and gene therapy | Jun 12, 2022 | Pending |
Array
(
[id] => 18077863
[patent_doc_number] => 20220403475
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-22
[patent_title] => REPORTER CONSTRUCTS, COMPOSITIONS COMPRISING THE SAME, AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/836483
[patent_app_country] => US
[patent_app_date] => 2022-06-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31394
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17836483
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/836483 | REPORTER CONSTRUCTS, COMPOSITIONS COMPRISING THE SAME, AND METHODS OF USE THEREOF | Jun 8, 2022 | Pending |
Array
(
[id] => 18149934
[patent_doc_number] => 20230023791
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-01-26
[patent_title] => GENE EDITING SYSTEMS COMPRISING A CRISPR NUCLEASE AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/830212
[patent_app_country] => US
[patent_app_date] => 2022-06-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 59784
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17830212
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/830212 | GENE EDITING SYSTEMS COMPRISING A CRISPR NUCLEASE AND USES THEREOF | May 31, 2022 | Pending |
Array
(
[id] => 17930187
[patent_doc_number] => 20220325312
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-13
[patent_title] => MODIFIED CYANOBACTERIUM, MODIFIED CYANOBACTERIUM PRODUCTION METHOD, AND PROTEIN PRODUCTION METHOD
[patent_app_type] => utility
[patent_app_number] => 17/748617
[patent_app_country] => US
[patent_app_date] => 2022-05-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14522
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17748617
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/748617 | MODIFIED CYANOBACTERIUM, MODIFIED CYANOBACTERIUM PRODUCTION METHOD, AND PROTEIN PRODUCTION METHOD | May 18, 2022 | Pending |
Array
(
[id] => 17990464
[patent_doc_number] => 20220356501
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-10
[patent_title] => ENGINEERED CELLS FOR INCREASED PRODUCTION OF DIFFICULT-TO-EXPRESS PROTEINS
[patent_app_type] => utility
[patent_app_number] => 17/740999
[patent_app_country] => US
[patent_app_date] => 2022-05-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4605
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17740999
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/740999 | ENGINEERED CELLS FOR INCREASED PRODUCTION OF DIFFICULT-TO-EXPRESS PROTEINS | May 9, 2022 | Pending |
Array
(
[id] => 17990451
[patent_doc_number] => 20220356488
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-10
[patent_title] => Asparaginase Based Selection System for Heterologous Protein Expression in Mammalian Cells
[patent_app_type] => utility
[patent_app_number] => 17/738896
[patent_app_country] => US
[patent_app_date] => 2022-05-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10562
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17738896
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/738896 | Asparaginase based selection system for heterologous protein expression in mammalian cells | May 5, 2022 | Issued |
Array
(
[id] => 18754358
[patent_doc_number] => 20230357763
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-09
[patent_title] => Morpholinos with Increased Delivery Efficiency
[patent_app_type] => utility
[patent_app_number] => 17/803316
[patent_app_country] => US
[patent_app_date] => 2022-05-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3126
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17803316
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/803316 | Morpholinos with Increased Delivery Efficiency | May 5, 2022 | Pending |
Array
(
[id] => 17983842
[patent_doc_number] => 20220349878
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-03
[patent_title] => DNA CAPTURE-BASED GRAVITATIONAL FLOW-THROUGH ASSAY FOR ANTIGEN DETECTION
[patent_app_type] => utility
[patent_app_number] => 17/733265
[patent_app_country] => US
[patent_app_date] => 2022-04-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11419
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 76
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17733265
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/733265 | DNA CAPTURE-BASED GRAVITATIONAL FLOW-THROUGH ASSAY FOR ANTIGEN DETECTION | Apr 28, 2022 | Pending |